• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在新冠疫情期间评估暴露风险以指导行为

Estimating Exposure Risk to Guide Behaviour During the SARS-COV2 Pandemic.

作者信息

Smyth Barry

机构信息

Insight SFI Research Centre for Data Analytics, University College Dublin, Dublin, Ireland.

出版信息

Front Digit Health. 2021 May 28;3:655745. doi: 10.3389/fdgth.2021.655745. eCollection 2021.

DOI:10.3389/fdgth.2021.655745
PMID:34713129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8521974/
Abstract

The end of 2020 and the beginning of 2021 was a challenging time for many countries in Europe, as the combination of colder weather, holiday celebrations, and the emergence of more transmissible virus variants conspired to create a perfect storm for virus transmission across the continent. At the same time lockdowns appeared to be less effective than they were earlier in the pandemic. In this paper we argue that one contributing factor is that existing ways of communicating risk-case numbers, test positivity rates, hospitalisations etc.-are difficult for individuals to translate into a level of personal risk, thereby limiting the ability of individuals to properly calibrate their own behaviour. We propose an new more direct measure of personal risk, , to estimate the likelihood that an individual will come into contact with an infected person, and we argue that it can play an important role, alongside more conventional statistics, to help translate complex epidemiological data into a simple measure to guide pandemic behaviour. We describe how exposure risk can be calculated using existing data and infection prediction models, and use it to evaluate and compare the exposure risk associated with 39 European countries.

摘要

2020年末至2021年初,对欧洲许多国家来说是一段充满挑战的时期,寒冷天气、节日庆祝活动以及更具传播性的病毒变种共同出现,为病毒在整个欧洲大陆的传播营造了一场完美风暴。与此同时,封锁措施似乎比疫情早期的效果要差。在本文中,我们认为一个促成因素是,现有的传达风险病例数、检测阳性率、住院人数等信息的方式,个人很难将其转化为个人风险水平,从而限制了个人适当调整自身行为的能力。我们提出了一种新的更直接的个人风险衡量指标,以估计个人接触感染者的可能性,并认为它可以与更传统的统计数据一起发挥重要作用,帮助将复杂的流行病学数据转化为一种简单的衡量指标,以指导应对疫情的行为。我们描述了如何利用现有数据和感染预测模型计算接触风险,并使用它来评估和比较39个欧洲国家的接触风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/38956142d214/fdgth-03-655745-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/9c570a2e3da7/fdgth-03-655745-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/9289f0593152/fdgth-03-655745-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/c445013c4609/fdgth-03-655745-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/38956142d214/fdgth-03-655745-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/9c570a2e3da7/fdgth-03-655745-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/9289f0593152/fdgth-03-655745-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/c445013c4609/fdgth-03-655745-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8521974/38956142d214/fdgth-03-655745-g0004.jpg

相似文献

1
Estimating Exposure Risk to Guide Behaviour During the SARS-COV2 Pandemic.在新冠疫情期间评估暴露风险以指导行为
Front Digit Health. 2021 May 28;3:655745. doi: 10.3389/fdgth.2021.655745. eCollection 2021.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
4
Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.动态面板数据分析与美国大都市地区 COVID-19 的监测:纵向趋势分析。
J Med Internet Res. 2021 Feb 9;23(2):e26081. doi: 10.2196/26081.
5
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.宿主对 SARS-CoV2 及现有肝脏和胃肠道疾病中新兴变异株的反应。
Front Cell Infect Microbiol. 2021 Oct 25;11:753249. doi: 10.3389/fcimb.2021.753249. eCollection 2021.
6
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
7
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
8
COVID-19 Contact Tracing as an Indicator for Evaluating a Pandemic Situation: Simulation Study.COVID-19 接触者追踪作为评估大流行情况的指标:模拟研究。
JMIR Public Health Surveill. 2023 Apr 6;9:e43836. doi: 10.2196/43836.
9
Tuberculosis结核病
10
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.估算非药物干预措施对欧洲 COVID-19 疫情的影响。
Nature. 2020 Aug;584(7820):257-261. doi: 10.1038/s41586-020-2405-7. Epub 2020 Jun 8.

引用本文的文献

1
The fading impact of lockdowns: A data analysis of the effectiveness of Covid-19 travel restrictions during different pandemic phases.封锁措施效果逐渐减弱:不同大流行阶段新冠病毒旅行限制措施有效性的数据分析。
PLoS One. 2022 Jun 17;17(6):e0269774. doi: 10.1371/journal.pone.0269774. eCollection 2022.
2
Using Venn Diagrams to Evaluate Digital Contact Tracing: Panel Survey Analysis.使用文氏图评估数字接触者追踪:面板调查分析。
JMIR Public Health Surveill. 2021 Dec 6;7(12):e30004. doi: 10.2196/30004.

本文引用的文献

1
Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis.评估无症状新冠病毒感染的程度及其社区传播潜力:系统评价与荟萃分析。
J Assoc Med Microbiol Infect Dis Can. 2020 Dec 31;5(4):223-234. doi: 10.3138/jammi-2020-0030. eCollection 2020 Dec.
2
Social distancing in America: Understanding long-term adherence to COVID-19 mitigation recommendations.美国的社交距离措施:理解对 COVID-19 缓解建议的长期遵守情况。
PLoS One. 2021 Sep 24;16(9):e0257945. doi: 10.1371/journal.pone.0257945. eCollection 2021.
3
Predictive performance of international COVID-19 mortality forecasting models.
国际 COVID-19 死亡率预测模型的预测性能。
Nat Commun. 2021 May 10;12(1):2609. doi: 10.1038/s41467-021-22457-w.
4
Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure.监测 COVID-19 暴露的芝加哥 SARS-CoV-2 IgG 抗体的模式和持久性。
JCI Insight. 2021 May 10;6(9):146148. doi: 10.1172/jci.insight.146148.
5
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China.中国武汉市及其他地区 SARS-CoV-2 的血清流行率和无症状携带者状态。
PLoS Negl Trop Dis. 2021 Jan 7;15(1):e0008975. doi: 10.1371/journal.pntd.0008975. eCollection 2021 Jan.
6
COVID-19 by numbers - infections, cases and deaths.按数字划分的 COVID-19 - 感染、病例和死亡。
Environ Microbiol. 2021 Mar;23(3):1322-1333. doi: 10.1111/1462-2920.15377. Epub 2021 Jan 5.
7
An estimation of undetected COVID cases in France.法国未被检测出的新冠病例估计数。
Nature. 2021 Feb;590(7844):38-39. doi: 10.1038/d41586-020-03513-9.
8
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.评估 SARS-CoV-2 刺突突变 D614G 对传染性和致病性的影响。
Cell. 2021 Jan 7;184(1):64-75.e11. doi: 10.1016/j.cell.2020.11.020. Epub 2020 Nov 19.
9
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.截至 2020 年 9 月美国估计的 SARS-CoV-2 血清流行率。
JAMA Intern Med. 2021 Apr 1;181(4):450-460. doi: 10.1001/jamainternmed.2020.7976.
10
Behavioral Fatigue: Real Phenomenon, Naïve Construct, or Policy Contrivance?行为疲劳:真实现象、单纯概念还是政策设计?
Front Psychol. 2020 Nov 5;11:589892. doi: 10.3389/fpsyg.2020.589892. eCollection 2020.